Sagility to buy US medical coding firm Chirok Health for up to $32.35 million
Representative image: DarkoStojanovic / Pixabay
Bengaluru-based Sagility's US arm signed a deal on 21 October 2026 to buy Tennessee's Chirok Health for $20 million upfront plus up to $12.35 million tied to performance.
What Happened
Sagility, the Bengaluru-headquartered healthcare services company, said its US subsidiary, Sagility (US) Holdings, signed a definitive agreement on 21 October 2026 to acquire all of Chirok Health, a Tennessee-based firm that provides medical coding, clinical documentation and revenue-cycle services to US healthcare providers. Sagility will pay $20 million in cash at closing and up to $12.35 million more if Chirok meets agreed performance targets, taking the total to as much as $32.35 million. Reports differed on whether the deal had already closed; Sagility's filing describes the agreement and the payment terms.
Key Facts
- Buyer: Sagility (US) Holdings, a subsidiary of Sagility Limited, which is listed in India.
- Target: Chirok Health LLC, Tennessee, founded in 2019.
- Price: $20 million upfront in cash, plus contingent payments of up to $12.35 million linked to performance milestones; maximum $32.35 million.
- Chirok's revenue: $12.7 million in 2023, $8.2 million in 2024 and $9.0 million in 2025, according to the company's disclosure as reported.
- Chirok's services: clinical documentation integrity, medical coding and revenue cycle management for hospitals and other providers.
- Canaccord Genuity acted as Chirok's exclusive financial adviser.
- Sagility's July-September 2026 revenue rose 22.5% to Rs 2,032.10 crore and profit after tax rose 13.3% to Rs 284.21 crore; interim dividend Rs 0.15 a share.
- The deal follows Sagility's acquisition of CareSeed in June 2026, which added quality-reporting services for health insurers.
Why It Matters
Sagility is one of India's larger healthcare business-process companies. It works for US health insurers (payers) and hospitals and clinics (providers), handling tasks such as claims processing, billing and coding, much of it from delivery centres in India. Its main investor is the private equity firm EQT. The company has been growing its provider business, and Chirok gives it more specialised capabilities in that market.
Medical coding is the process of turning doctors' notes and hospital records into standard codes that insurers use to pay claims. Clinical documentation integrity is the work of making sure those records are complete and accurate, so that hospitals are paid correctly and do not face audits. Both are labour-intensive and increasingly use artificial intelligence (AI) to read records and suggest codes, which is how Sagility has described its strategy for the acquisition.
For India, deals like this show how Indian-headquartered service companies are buying small US firms to gain clients and specialist skills, and then delivering much of the work from India. Revenue-cycle and coding work employs many graduates in life sciences, nursing and pharmacy in India.
The deal is small relative to Sagility's size, and the structure limits risk: more than a third of the price depends on Chirok's future performance. Chirok's revenue has also been uneven, falling from $12.7 million in 2023 to $8.2 million in 2024 before recovering to $9.0 million in 2025.
The announcement came with Sagility's results for the July to September 2026 quarter. Revenue from operations rose 22.5% from a year earlier to Rs 2,032.10 crore, or 12.2% in constant currency, and profit after tax rose 13.3% to Rs 284.21 crore. The board declared an interim dividend of Rs 0.15 a share, with a record date of 30 October 2026.
| Item | Detail |
|---|---|
| Agreement signed | 21 October 2026 |
| Upfront payment | $20 million |
| Performance-linked payment | up to $12.35 million |
| Chirok revenue, 2025 | $9.0 million |
Impact
Short-term: Sagility adds Chirok's clients and staff once the deal closes, and investors will look for detail on how quickly the business adds to revenue.
Long-term: If the integration works, Sagility can offer US hospitals a fuller set of revenue-cycle services and move more of the work to its delivery centres, supporting jobs in India.
Who is affected: Sagility's shareholders and employees, Chirok's staff and clients, and graduates seeking healthcare-services jobs in India.
Key Takeaway
Sagility has agreed to buy US medical coding and documentation firm Chirok Health for up to $32.35 million, with $12.35 million tied to performance, to deepen its business with American hospitals.
Questions and Answers
What is Sagility acquiring?
Chirok Health LLC, a Tennessee-based company founded in 2019 that provides clinical documentation, medical coding and revenue-cycle services to US healthcare providers. The agreement was signed on 21 October 2026.
How much is Sagility paying for Chirok Health?
$20 million in cash at closing plus up to $12.35 million in performance-linked payments, for a maximum of $32.35 million.
Why is Sagility buying Chirok Health?
The deal expands Sagility's services for US hospitals and clinics in documentation and coding. It is small relative to the company, and a large part of the price depends on Chirok's performance, which limits the risk.
What is medical coding?
It is the conversion of doctors' notes and hospital records into standard codes that insurers use to process and pay claims.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
Sourced and fact-checked by the Peepals Global Editorial Team
WhatsApp SIM binding from January 1, 2027: what changes for users
ITB Asia 2026: Kerala, J&K, MP pitch experiential travel in Singapore
Reported, fact-checked and published by the Peepals Global Editorial Team.
